Skip to main content
VCbacked
Log inGet Started

Atrandi Biosciences

Vilnius, Lithuania

Atrandi Biosciences is a Lithuanian biotech startup that aims to commercialize droplet microfluidics technology.

$25.0M raised
Feb 2025
Series A
BiotechnologyLife SciencePharmaceutical

Top Investors

Vsquared VenturesLux CapitalMicrosoftPractica CapitalGRIDS Capital

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Atrandi Biosciences

How much funding has Atrandi Biosciences raised?
Atrandi Biosciences has raised $25.0M in total funding. The most recent round was Series A. The last funding was announced in February 2025.
Who are Atrandi Biosciences's investors?
Atrandi Biosciences's investors include Vsquared Ventures, Lux Capital, Microsoft, Practica Capital, GRIDS Capital.
Where is Atrandi Biosciences headquartered?
Atrandi Biosciences is headquartered in Vilnius, Lithuania.
What does Atrandi Biosciences do?
Atrandi Biosciences is a Lithuanian biotech startup that aims to commercialize droplet microfluidics technology.
What stage is Atrandi Biosciences at?
Atrandi Biosciences is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Atrandi Biosciences — Funding & Investors." VCBacked, February 18, 2025, https://www.vcbacked.co/company/atrandi-biosciences. Accessed June 4, 2026.
APA
VCBacked. (2025). Atrandi Biosciences — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/atrandi-biosciences
Wikipedia (cite web)
{{cite web |title=Atrandi Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/atrandi-biosciences |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong